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 Gene-based meta-analysis of GWAS data identifies independent SNPs in ANXA6 as 
associated with SLE in Asian populations  
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Abstract 
Background: Previous genome-wide association studies (GWAS), which were 
mainly based on single variant analysis, have identified many susceptibility loci for 
systemic lupus erythematosus (SLE). However, the genetic architecture of this 
complex disease is far from understood. A gene-based analysis may help identify 
novel loci by considering global evidence of association from a gene or a genomic 
region rather than focusing on evidence from individual variants. Methods: Based on 
meta-analysis results of two SLE GWASs, we performed gene- and region-based 
Page 6 of 58
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
6 
 
analysis followed by replication with a total of 4,626 cases and 7,466 controls of 
Asian ancestry. Allelic differential expression was measured by pyrosequencing. 
Results: Over half of the reported SLE susceptibility loci showed evidence of 
independent effects, which is important for understanding the mechanisms of 
association and explaining disease heritability. ANXA6 was detected as a novel 
susceptibility gene for SLE with several SNPs contributing independently to disease 
association. The risk allele of rs11960458 correlated significantly with increased 
expression of ANXA6 in PBMCs of heterozygous healthy controls. Several other 
associated SNPs may also regulate ANXA6 expression based on data from public 
databases. Higher expression of ANXA6 in SLE cases was also reported previously. 
Conclusion: Our study demonstrated the merit of gene-based analysis in identifying 
novel susceptibility loci, especially those with independent effects, and also 
demonstrated a widespread presence of independent contributors in susceptibility 
genes for SLE.   
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Gene-based analysis, GWAS, SLE susceptibility, ANXA6 
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Introduction 
So far more than 50 loci were shown to have robust association with systemic 
lupus erythematosus (SLE) (1-23). However, its genetic basis is far from understood 
(24) . Several limitations may have contributed to the phenomenon of “missing 
heritability”. Firstly, genetic variants may have different allele frequencies or linkage 
disequilibrium (LD) structures across major ethnicities, or even in different 
populations of the same ethnicity, so the pattern of disease association might be 
different between different populations (25), making it difficult to replicate previous 
findings and to predict risk. It is also possible that different variants in a gene having 
no LD to each other are associated with the underlying disease in different 
populations similar to what was shown for IRF8 (15). Thus, replication efforts from 
different populations that focused on single reported SNPs may miss the association 
signal.  
The second limitation may come from the insufficient exploration of independent 
effects within an individual locus. These independent contributors are often 
overlooked in the subsequent replication steps, and the validation of their effects may 
require much larger sample sizes than available in most studies. Additionally, the 
coverage of many genomic regions in the early stage SNP chips was also limited; 
hence reducing the chances of capturing independent contributors. However, there 
was strong support on the contribution from multiple independent effects from a 
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single locus to disease susceptibility. A recent study demonstrated multiple 
independent contributors in a number of risk loci for several complex diseases, and 
those independent contributors within a locus could explain more disease heritability 
than the single reported SNP (26). The same scenario might also be true for SLE. Two 
out of five loci showed evidence of independent effects in our recent study on SLE in 
Asian populations (15), and detection of independent contributors near an established 
locus was also reported recently (27). 
Gene- or region-based association analysis is an approach that may improve the 
power of GWAS. Generally, this approach tests whether a set of SNPs in a given gene 
or region shows evidence of association with a trait of interest. Gene-based analysis 
has several attractive advantages(28). Firstly, by focusing on the association signal 
from the entire gene rather than the individual SNPs, it could detect associated genes 
with multiple independent effects of small effect size, which could have been missed 
by a single variant-based analysis. Besides, gene-based analysis can also alleviate the 
issue resulted from insufficient chip coverage of earlier GWASs (29). The effect from 
the untyped causal SNP might be captured more efficiently via detecting the joint 
effect of multiple markers that are in LD with it. In addition, this approach also 
reduces the multiple-testing burden of GWAS, since it only requires correction for 
~20,000 genes rather than the hundreds of thousands of SNPs tested in a typical 
GWAS. Furthermore, the characteristics of a gene, such as its position, sequence, and 
function, are highly consistent across human populations. Therefore, gene-based 
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analysis is more likely to yield consistent results across major ethnicities, and it also 
provides an opportunity for understanding genetic findings at the functional level (25, 
30).  
Several gene-based association methods have been proposed, such as 
regression-based tests(25) and integration of the SNP-based test statistics or P values 
from a gene (31, 32). In the regression-based tests, all the SNPs in the genes are 
entered as predictor variables simultaneously, except for the redundant SNPs. This 
approach might suffer from low statistical power due to the high dimensionality. In 
addition, the requirements of raw genotype data and heavy computational demand 
also limited their application on a genome-wide scale. Recently, Li et al. (28) 
proposed GATES (Gene-Based Association Test using Extended Simes procedure) as 
an efficient approach for gene-based test via combination of SNP statistics. Using an 
extended Simes procedure, GATES integrates the P values of all the contributing 
SNPs within a gene and its up- and down-stream regions, obtaining an overall 
association P value for the gene. It could achieve comparable statistical power to 
other alternative gene-based analysis methods, and showed better performance when a 
gene has only one independent signal(28). This method has been successfully applied 
in the identification of variants conferring risk of schizophrenia in Han Chinese(33).   
In this study, based on the meta-analysis of two SLE GWASs conducted on two 
Chinese populations (15), we performed an in-depth gene-based analysis by GATES 
and followed the findings by replication in a total of 4,626 cases and 7,466 controls in 
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several Asian cohorts. Our results confirmed most SLE susceptibility genes identified 
previously at the single SNP level, and showed widespread presence of independent 
effects among these genes. In addition, we identified ANXA6 as a novel SLE 
susceptibility gene with multiple independently contributing variants, and the results 
provide new insight on the genetic architecture of this prototypic autoimmune disease.  
 
 
Materials and Methods 
Subjects 
Samples used in this study were overlapped with our previous study (15). Briefly, 
samples were collected from Hong Kong (612 cases and 2193 controls in the GWAS 
stage, and 1027 cases and 1706 controls in the replication panel), Anhui Province, 
China (1044 cases and 1201 controls in the GWAS stage, and 1463 cases and 1398 
controls in the replication panel) and Bangkok, Thailand (480 cases and 968 controls 
in the replication stage), respectively. The Hong Kong cases were SLE patients 
visiting five hospitals in Hong Kong: Queen Mary Hospital, Tuen Mun Hospital, 
Queen Elizabeth Hospital, Pamela Youde Nethersole Eastern Hospital and Princess 
Margaret Hospital. They were all of self-reported Chinese ethnicity living in Hong 
Kong. Controls for the Hong Kong cohort were healthy blood donors from the Hong 
Kong Red Cross (for the Hong Kong Replication Panel) and individuals from other 
GWAS studies  performed  in the University of Hong Kong, genotyped on the same 
Page 11 of 58
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
11 
 
platform at the same time (GWAS stage). The samples for Anhui GWAS were 
obtained from several hospitals in two geographic regions (central and southern China) 
and the corresponding controls were clinically assessed to be without SLE, other 
autoimmune disorders, systemic disorders or family history of autoimmune diseases. 
SLE cases for Replication from Anhui were all self-reported Chinese ethnicity living 
in Anhui Province, attending Departments of Rheumatology at Anhui Provincial 
Hospital and the First Affiliated Hospital of Anhui Medical University in Hefei, 
Anhui Province, China. Controls were chosen from a pool of healthy blood donors 
recruited from Hefei, Anhui province, with an effort to match for the age and gender 
of the corresponding SLE patients. The Thai cases were SLE individuals visiting King 
Chulalongkorn Memorial Hospital, Bangkok. Thai controls were recruited from 
unrelated voluntary healthy donors from the same ethnic background and geographic 
area as the Thai SLE cases. All cases recruited in this study had medical records 
documenting fulfillment of the revised criteria of the American College of 
Rheumatology for diagnosis of SLE. The studies were approved by the respective 
Institutional Review Board of all the institutions listed above, and all subjects gave 
informed consent. 
 
Genotyping 
The two GWASs from Hong Kong and Anhui were conducted as previously reported 
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(15), both by Illumina 610-Quad Human Beadchip array. Further replication on 
selected SNPs was performed by TaqMan SNP genotyping method using 
assay-on-demand probes and primers (Applied Biosystems, Foster City, CA, USA), 
Catalogue nos. C__8723142_10 for rs1561535, C__29329619_10 for rs6707773, 
C__25934588_10 for rs3815700, C__11836916_10 for rs4958893, C__31986133_10 
for rs11960458, C__29349750_10 for rs6896621, C__7513840_20 for rs868531, 
C__15758511_10 for rs2303028, C__3169127_20 for rs10036748. The accuracy of 
genotyping was confirmed by direct sequencing of PCR products for 96 randomly 
chosen samples, which showed 100% concordance. Genotyping concordance between 
Illumina Human 610-Quad Beadchip and Taqman SNP genotyping method was also 
checked on randomly selected samples and the two methods showed complete 
concordance.  
 
Association analysis 
The association analysis and meta-analysis were performed as previously described 
(15). The quality control process included removing SNPs with low call rate (<90%), 
low minor allele frequencies (<1%), and violation of Hardy-Weinberg equilibrium in 
controls (P ≤ 10−4), and removing samples with low call rate (<90%) and hidden 
relationship detected using PLINK (32). Then we applied two principle components 
(PCs) corrections to the whole genome association statistics on the two GWAS 
datasets. Two major PCs, PC1 and PC2 were added as covariates to adjust for 
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population stratification. PC1 and PC2 were calculated by EIGENSOFT 5.0 using the 
whole genome data, and SNPTEST was performed for association analysis. Then 
meta-analysis was done by METAL(34). Imputation was performed on Hong Kong 
and Anhui subjects from GWAS stage by IMPUTE2.1.1, using SNP genotypes of 286 
Asians from the 1000 Genome project (June 2011 data release) as the reference. 
Imputed SNPs with an information score >0.9 were included for further analyses. The 
same quality control criteria were applied to process imputed SNPs.  
Joint analysis of association, taking into consideration the differences between cohorts, 
was performed using Cochran-Mantel-Haenszel, and homogeneity of effect size 
between diverse cohorts and different stages of the study was examined by 
Breslow-Day test (P_het in Table 2), both installed in PLINK. Test of independent 
effects towards disease association for SNPs in a single locus was done using logistic 
regression by PLINK, adjusted by the effect of the other SNPs in the same locus, also 
treating cohort as a covariate. 
 
Gene-based and region-based analysis 
GATES (28), which implemented in KGG (35) software package was used to perform 
gene-based analysis. SNPs were mapped onto genes according to gene coordinate 
information from NCBI GRCh37, and SNPs within 10 kilobase pairs (kb) both 
upstream and downstream of each gene were also included.  A SNP that was located 
in the overlapping region of two genes was assigned into both genes. The r-square (r
2
) 
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values from the HapMap CHB+JPT samples were used to adjust for marker 
dependency, and SNPs in high LD (r
2≥0.8) were merged.   
The construction of Gene-Based-Association P values was done as described 
previously(28). Briefly, let P(1), …, P(m) be the ascending p values of m SNPs within a 
gene, the overall P value for the gene is calculated as follows: 
 =  	
()	()  
Where me is the effective number of independent P values among the m SNPs and me(j) 
is the effective number of independent P values among the top j SNPs.  
The value of me is estimated to be M− ∑ (λi > 1)(λi − 1)λi > 0 , where I(x) is 
an indicator function and λi is the ith eigenvalue of the p value correlation coefficient 
matrix [ρi,j] of SNP-based statistic tests. When the SNPs were all independent, the 
eigenvalues were set at 1, so that me was equal to the number of SNPs. When all the 
SNPs were in absolute LD, the first eigenvalue was equal to the number of SNPs and 
the rest were equal to 0, so that me =1. For intermediate situations, the P value 
correlation coefficient ρ could be accurately approximated by a six-order polynomial 
function of the pair-wise allelic correlation coefficient r, and   will thus have an 
approximate uniform (0,1) distribution.  
After correction for multiple testing, the significance level for Benjamini & Hochberg 
(1995) FDR test (36) to control the error rate at 0.05 on the whole genome was 2.0E-4 
for the 23,411 genes tested. Briefly, the P values of each gene are ranked in ascending 
order and denoted by P(1)…P(m). Then, the Benjamini & Hochberg procedure controls 
the false discovery rate (α=0.05 here). The procedure works as follows: 1) For a given 
α, find the largest κ such that () ≤  !"; 2) Then reject all H(i) for i=1,…, κ. Results 
Page 15 of 58
John Wiley & Sons
Arthritis & Rheumatology
This article is protected by copyright. All rights reserved.
15 
 
from genes with P < 2.0E-4 were presented. 
We designed a modification that would allow consideration of all the intergenic 
regions in GATES. We applied the sliding window algorithm with a window size of 
200kb and 100kb overlap between two neighboring windows to let GATES treat all 
the intergenic regions as if they have real genes located within. This modification 
allowed us to analyze 43,729 autosomal regions in total (including both real genes and 
“artificial genes”) using GATES for analysis of association.  
 
 
Allele-Specific Transcription Quantification 
Briefly, 43 healthy individuals heterozygous for rs11960458 were recruited for 
investigation of the relative ANXA6 mRNA levels expressed from the two alleles, “T” 
and “C” using pyrosequencing. DNA detection was used as an internal control for 
normalization of the expression. Total RNA obtained from PBMCs from each 
individual were treated with DNAase first. Both cDNA and genomic DNA from the 
same individuals were amplified by PCR, and the PCR amplicons were then purified 
with the QIAquick PCR purification kit. The sequencing primers were designed with 
Pyrosequencing Assay Design Software v1.0. Reactions were then performed on a 
Biotage PSQ96MA machine, and allele quantification was analyzed by PSQMA 2.1 
software. The ratio of T:C allelic detection was performed for both DNA and cDNA, 
with the ratio on DNA being used as a means of normalization on the detection 
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efficiency. A paired Student’s t test was adopted to compare the expression level from 
the “T” and the “C” alleles for this gene.  
 
Web resources 
The URLs for data presented herein are as follows 
PLINK version 1.07,http://pngu.mgh.harvard.edu/~purcell/plink/ 
SNAP, http://www.broadinstitute.org/mpg/snap/ 
Haploview, http://www.broad.mit.edu/mpg/haploview/ 
GHS Express, http://genecanvas.ecgene.net/uploads/ForReview/ 
NEXTBIO, https://www.nextbio.com/ 
BioGPS, http://biogps.org 
SCAN, http://www.scandb.org/ 
RegulomeDB: http://www.regulomedb.org/ 
EIGENSOFT: https://github.com/DReichLab/EIG 
SNPTEST: https://mathgen.stats.ox.ac.uk/genetics_software/snptest/snptest.html 
 
 
 
Results 
Gene-based association analysis 
As reflected by the results after adjusting for admixture by principle components 
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analysis (PCA), the two Chinese populations did not seem to have significant 
differences in terms of population structure. There was no substantial difference for 
the SNP-based P values before and after admixture adjustment, as majority (99.83%) 
of them differed within one order of magnitude (Figure S1). SNP-based P values after 
admixture adjustment were subjected to gene-based analysis using GATES. A total of 
324,519 (60.44%) SNPs were mapped to one or more of the 23,411 genes. The 
inflation factor of gene-based association was 1.047. We examined the 
Quantile-Quantile plot (Q-Q plot) comparing expected and observed gene-based P 
values by removing genes in known susceptibility loci (4-6, 9, 10, 12-16, 18-20, 23, 
27). After removal of these genes, we still observed an excess of association signal 
(Figure S2), suggesting additional associated genes for the disease. After correction 
for multiple testing, 83 genes reached gene-based genome-wide significance 
(P<2.0E-04), of which 41 genes were located in non-MHC regions. Twenty-five of 
the 41 genes within 18 loci were located in regions already established for SLE 
association in earlier studies based on single variant analysis (Table 1).  Some of 
these genes are close to each other and located in the same LD block, thus were 
assigned into the same locus, such as LRRC18 and WDFY4, HIC2 and UBE2L3, and 
BLK and FAM167A.  
It was shown that Ten of the eighteen known SLE susceptibility loci showed 
potential evidence of containing multiple independent contributors (P_adjusted<0.05 
and P_unadjusted<0.001, Table 1, upper panel). The independent effects within nine of 
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them (except for CLEC16A) have already been confirmed via direct or indirect (by 
surrogate variants having high LD with them, r
2
>0.8)  tagging of at least one 
independent contributor by previous replication studies (4, 6, 12, 13, 15, 27, 37-40). 
Therefore, the results of gene-based analysis were proven consistent with what have 
been reported in the literature. For other potentially independent variants in the 
reported loci that did not reach genome-wide significance, their roles in disease 
association need confirmation through replication in additional samples.  
The results also suggested 16 novel non-MHC genes within 13 loci might be 
associated with SLE. Three of them showed potential evidence of independent effects 
(Table S1). Thus, we performed replication on the best SNPs of these three loci, using 
2,970 additional SLE cases and 4,072 controls collected from Hong Kong, Anhui and 
Thailand. A joint analysis of results from all three cohorts showed that an intronic 
variant in ANXA6 (annexin Ⅵ) demonstrated significant SLE association (rs4958893, 
P_combined=3.12E-07, Table S2), and this locus was followed up further. A flowchart 
describing the steps taken in the current study was shown in Figure 1. 
 
Region-based association analysis 
In order to detect association signals located in the intergenic regions, we designed a 
modification that would allow consideration of all the intergenic regions in a 
gene-based analysis (See Materials and Methods for details). After correction for 
multiple testing, we found additional 38 intergenic regions reaching genome-wide 
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significance of gene-based test. Seventeen of them were located in or near the MHC 
region, and the others were mostly in high LD with the know loci, or candidate loci 
identified by the analysis that only considered the real gene regions, such as those 
where ETS1, TNFSF4, CDKN1B, and ANXA6 are located (Detailed results were 
shown in Table S3). Interestingly, with such modification, we further identified 
association signals from miR146a, PRDM1 and IKZF1 regions that were missed from 
analysis when the intergenic regions were not systematically considered. 
 
ANXA6 locus in association with SLE 
We examined the meta-analysis results in ANXA6 region, and there were eleven 
SNPs that showed P_meta <0.001 (Table S4 and Figure 2a), and LD patterns among 
them revealed that they could be grouped into five clusters (Figure S3). Imputation 
followed by meta-analysis was performed to obtain information on additional SNPs in 
this region. However, none of those imputed SNPs showed P values of higher 
significance than the interrogated SNPs. Additionally, there is no adequate evidence 
supporting their independent functional potentials on disease pathogenesis that would 
warrant additional replication. For example, none of them resulted in amino acid 
substitutions (Table S5, by SCAN annotation). RegulomeDB annotations were also 
investigated to identify SNPs in or near regulatory elements, and several such imputed 
SNPs were shown to have potential regulatory functions. However, these SNPs were 
all shown to have high LD with the genotyped SNPs (Table S5, RegulomeDB 
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annotation). Therefore, four additional SNPs, namely rs11960458, rs6896621, 
rs868531, and rs2303028, all interrogated in the GWAS stage, were selected for 
further replication to identify independent effects within ANXA6. In order to exclude 
the possibility that the association of ANXA6 with SLE was dependent on the effect of 
the neighboring TNIP1, a gene that was previously reported for SLE association (13), 
SNP rs10036748 was also included for replication in additional samples. 
Results in Table 2 showed that both rs11960458 and rs6896621 revealed suggestive 
significance for SLE association by joint analysis of data from all three cohorts 
(P_combined =5.66E-07 and 6.72E-06, respectively). The association of SNP 
rs10036748 in TNIP1 was also replicated in the current study (P_combined =1.94E-10). 
For SNPs rs4958893, rs11960458, rs686921 and rs10036748, the same trends were 
observed in all the replication cohorts (Figure S4). Importantly, independence tests 
showed that SNPs rs4958893, rs11960458, and rs6896621 remained significant when 
the effect from rs10036748 in TNIP1 was adjusted for (shown as conditional P
a
). 
Furthermore, independent effects also existed among these four SNPs, since each SNP 
remained significant when the effects from the other three SNPs were all adjusted for 
(shown as conditional P
b
).  Consistent with the results of independence tests, these 
SNPs had low to moderate LD between each other (r
2
 < 0.4, Figure 2b). In addition, 
the extended association down to GPX3 observed from the data might be due to the 
TNIP1 association, as indicated by the LD pattern between rs10036748 and the SNPs 
in this region (Figure S5). SNPs in GPX3 were in moderate to high LD with 
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rs10036748, and their P values were no longer significant when the effect from 
rs10036748 was adjusted for by logistic regression (Shown in Table S6). 
 
 
ANXA6 expression profile and eQTL analysis 
In order to detect potential functions of the SNPs in transcription regulation, we 
queried the publicly available expression quantitative trait locus (eQTL) database 
GHS Express, which assessed the transcriptome of circulating monocytes in 1,490 
unrelated individuals (41). We found that rs4958893 was in absolute LD (r
2
=1) with 
rs868641, a cis eQTL for ANXA6 (P=3.41E-11). Additionally, the regulatory effect of 
rs868641 on ANXA6 expression in monocytes has also been confirmed by a recent 
study on cell type-specific eQTL analysis (42). SNP rs11960458 was also in high LD 
(r
2
=0.94) with another cis eQTL for ANXA6 (rs4958891, P=1.41E-10). Detailed 
results of the eQTL analyses were shown in Table S7-S8.  
 
Interestingly, SNP rs11960458 is located in the 3’UTR of ANXA6 and we speculated 
that it may affect the expression level of ANXA6 or is in high LD with a variant that 
does. Therefore, we examined allelic differential expression of ANXA6 from the two 
alleles of rs11960458 in peripheral blood mononuclear cells (PBMCs) from healthy 
individuals of Hong Kong Han Chinese population who are heterozygous on the SNP 
(n=43). The risk allele (T) was found to be significantly correlated with a higher level 
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of ANXA6 expression (P=0.0017, Figure 3). The result suggested that rs11960458, or 
SNP(s) in high LD with it, might play a regulatory role and may predispose the risk 
allele carriers to SLE through increased expression of ANXA6. 
 
 
Discussion 
In this study, using gene-based test of meta-analysis results from two Asian 
GWASs, we confirmed multiple SLE susceptibility genes that were established before, 
and showed the widespread presence of independent effects among known 
susceptibility genes for SLE. Importantly, we identified ANXA6 as a novel 
susceptibility gene for SLE, which contained several independent contributors. 
ANXA6 did not contain a single SNP that could potentially reach genome-wide 
significance based on the current sample size, their effect size and allele frequency. 
Thus, the association of this gene would not have been recognized without application 
of an alternative approach such as the gene-based association analysis. We also 
identified rs11960458 as a regulatory SNP (rSNP) with its risk allele correlating with 
higher expression of ANXA6, providing a functional interpretation for the genetic 
association.  
ANXA6 showed high expression level in immune-related cells, and increased 
expression of ANXA6 was also observed in SLE cases (Figure S6-S7). In addition, 
ANXA6 protein was shown to interact with human complement receptor 2 
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(CR2/CD21) in an earlier study (43). CR2 is the receptor for complement C3Dd and 
Epstein-Barr virus (EBV) binding on B and T cells, and plays a central role in the 
immune responses to foreign antigens and the development of autoimmunity to 
nuclear antigens in SLE (44). EBV has been considered as an important 
environmental trigger for SLE (45, 46). Additionally, genetic variations in CR2 were 
found to be associated with SLE (47, 48). Thus, the potential functional link between 
ANXA6 and CR2 supported the genetic findings on ANXA6 as a novel SLE 
susceptibility gene.  
Furthermore, two variants in ANXA6 (SNP rs4958893, and rs11960458) were in 
high LD with eQTLs that affecting ANXA6 expression. SNP rs11960458 , which is 
located in the 3’UTR of ANXA6, showed evidence of allelic differential expression 
with the risk allele correlating with a higher expression of ANXA6. These data indicate 
that multiple mechanisms may be involved in the disease association of this locus. 
Interestingly, rs11960458 was also mapped onto a miRNA binding site of ANXA6 in 
Sanger’s miRBase (http://www.mirbase.org/). Destruction of the miRNA binding site 
(such as for miR-1234-3p and miR-4479) by this SNP might confer increased 
expression/stability although the detailed mechanisms still require further 
investigation. A summary of the current findings and the potential link between 
ANXA6 with autoimmunity were shown in Figure 4.   
The current study also suffers from several limitations and the exploration of SLE 
susceptibility genes is by no means complete. Genes like ARID5B, ITGAM, and 
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DRAM1, whose associations have been identified in our previous studies, did not 
show strong evidence of association when analyzed at the gene level. One of the 
underlying reasons is the definition of gene boundary. As reported by the ENCODE 
(The Encyclopedia of DNA Elements) project, the majority of the regulatory elements 
are located close to the gene although distant ones do exist (49), herein, the gene 
boundary was defined as 10kb up- and down-stream of each gene in the current study. 
The range of gene boundary, which determines the number of SNPs to be analyzed for 
the gene, may affect the results of gene-based associations. It is also important to 
recognize that there is a tradeoff for the gain in power for this method, since it may 
mask or dilute individual SNP effects when the SNPs in a gene are considered 
altogether, especially for large genes, such as ARID5B, DRAM1, and ITGAM as 
mentioned above. The lack of convincing signal in ITGAM might also be attributable 
to the low allele frequency of risk SNPs in this gene in Asian populations (MAF<5%, 
(11)). 
In addition, a gene-based analysis can only cover SNPs within or near a gene, and 
some intergenic SNPs may also be associated with complex diseases and could be 
missed by this approach. In order to solve this issue, we designed an in-house 
algorithm to consider all the intergenic regions larger than 10kb in a gene-based 
association analysis. We found that most of the intergenic regions that showed 
significant association signals were those in high LD with the known association loci 
or candidate loci identified by the analysis only considered the real genes. 
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Interestingly, with such modification, we successfully identified the association 
signals from miR146a, PRDM1 and IKZF1, which were not prominent by the 
gene-based method using a strict definition of genes. This region-based approach 
might find its usefulness in applying in the studies of other complex diseases. We 
have made this modification available from our laboratory website 
(paed.hku.hk/genome). 
 
 Recently, a re-sequencing-based study was conducted on 24,892 subjects with 
six autoimmune disease phenotypes and 17,019 controls (50). It concluded that many 
common variants with weak effect might have significant contribution to the missing 
heritability for complex diseases. These results support the merit of using gene-based 
approach for exploring independent effects in susceptibility loci for complex diseases. 
Additionally, with the support of many integrated bioinformatics databases, the 
application of gene-based approach could be further extended to explore novel 
biological pathways and protein-protein interaction networks that may play an 
important role in complex diseases. 
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Figure legends 
Figure 1. Flowchart of the experimental process and SNP selection criteria.  
 
Figure 2. Associated SNPs in TNIP1-ANXA6 region and LD patterns among these 
SNPs in the current study. (a) SNPs are plotted by chromosomal position (NCBI 
genome build 36.3; x axis) and meta-analysis P values (-log10P value; y axis). SNP 
rs4958893, having the strongest signal of ANXA6, is labeled in the plot, and other 
SNPs are colored to reflect their LD with rs4958893 (based on pairwise r
2
 values 
from the meta-analysis data). The reported SNP in TNIP1 (rs10036748) is underlined. 
Estimated recombination rates (from HapMap CHB+JPT samples) are plotted to 
reflect the local LD structure. The figure was generated using SNAP. (b) Shown are r
2 
values for CHB+JPT individuals in HapMap3 Release 2. Stars point to the reported 
SNP in TNIP1 gene. 
 
Figure 3. Allelic differential expression of ANXA6 based on SNP rs11960458 in 
PBMCs of healthy individuals. PBMC cDNA and DNA prepared from 43 healthy 
individuals heterozygous on rs11960458 were used for allelic differential expression 
analysis of ANXA6 by pyrosequencing. Shown are the ratio of T/C allelic detection for 
both DNA and cDNA. The median T/C ratio for DNA is 1.08 (95% CI: 1.07-1.11) and 
the median T/C ratio for cDNA expression is 1.18 (95% CI: 1.15-1.29), P=0.0017 by 
paired student’s t test on the difference of the ratios.  
 
Figure 4. Summary of association result of ANXA6 with SLE and its potential 
functional link with autoimmunity. 
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Table 1. Gene-based association analysis confirms association of the known SLE susceptibility loci and reveals independent variants. 
Known SLE susceptibility loci with evidence of independent effects         
Chr Gene P_Gene 
Best 
reported 
SNP 
P_Best 
Candidate 
Independent 
SNPs  
P_adjusted P_unadjusted 
Reported independent 
SNPs 
Marker 
dependency* 
1 TNFSF4 1.79E-08 rs2205960 6.97E-14 rs1418190 7.10E-05 1.30E-05 rs10798269 (Ref.(4, 13)) r
2=0.83 
          rs1418191 1.90E-04 5.98E-05     
          rs1539259 2.08E-04 6.28E-05     
          rs1578624 2.52E-04 8.08E-05     
          rs704840 1.91E-02 9.77E-12 rs704840 (Ref.(12)) Direct tagging 
2 STAT4 1.04E-19 rs7574865 6.22E-21 rs16833239 2.83E-05 5.02E-10     
          rs7594501 3.56E-05 6.96E-10     
          rs3771327 6.08E-05 2.95E-08     
          rs1400656 7.16E-05 5.08E-09     
          rs7601754 1.33E-04 2.43E-10 rs7601754 (Ref.(13, 37)) Direct tagging 
          rs7572482 9.25E-04 0.004297     
          rs10931481 1.14E-03 1.07E-06     
          rs1517352 2.09E-02 6.59E-06     
          rs6740131 3.19E-02 6.19E-05     
2 TET3 2.25E-06 rs6705628 3.85E-07 rs4852324 8.71E-03 3.29E-08 rs4852324 (Ref.(15)) Direct tagging 
          rs940296 8.64E-03 2.10E-08  rs4852324 (Ref.(15))  r
2
=0.92 
4 BANK1 4.10E-05 rs4522865 9.26E-07 rs10516487 2.27E-02 2.76E-05 rs10516487 (Ref.(6, 12)) Direct tagging 
6 UHRF1BP1 4.26E-12 rs13205210 5.51E-12 rs3734266 2.38E-02 7.17E-13 rs11755393 (Ref.(38)) Direct tagging 
7 IRF5 2.88E-09 rs4728142 7.80E-09 rs729302 1.48E-06 8.84E-10 rs729302 (Ref.(12, 13)) Direct tagging 
10 LRRC18_WDFY4 1.47E-06 rs1913517 2.52E-06 rs877819 2.03E-04 2.21E-08 rs877819 (Ref.(13, 39)) Direct tagging 
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rs2943244 1.56E-02 1.48E-06     
          rs2663052 3.83E-02 1.27E-07 rs7097397 (Ref.(12)) r2=0.81 
12 CDKN1B 6.48E-06 rs10845606 6.05E-06 rs12822507 4.26E-03 0.000203 rs12822507 (Ref.(15)) Direct tagging 
          rs11055008 1.17E-02 6.16E-07     
16 CLEC16A 4.29E-06 rs12599402 1.04E-07 rs17673553 1.91E-02 0.00065     
22 HIC2_UBE2L3 2.72E-07 rs463426 0.000289 rs5754217 7.51E-03 2.99E-05 rs5754217 (Ref.(13, 40)) Direct tagging 
          rs4821112 8.65E-03 3.76E-05     
Known SLE susceptibility loci without evidence of independent effects 
Chr Gene P_Gene 
Best 
reported 
SNP 
P_Best 
Candidate 
Independent 
SNPs  
3 CD80 1.33E-04 rs6804441 9.24E-06 N 
5 TNIP1 6.75E-05 rs10036748 3.10E-06 N 
6 TNFAIP3 8.81E-13 rs2230926 2.20E-13 N 
8 BLK_FAM167A 1.81E-12 rs7812879 2.88E-13 N 
11 ETS1 5.22E-05 rs6590330 1.37E-07 N 
12 SLC15A4 3.55E-08 rs1385374 2.58E-09 N 
13 ELF1 5.86E-05 rs7329174 6.21E-06 N 
22 YDJC 2.61E-07 rs2298428 1.31E-07 N     
P_Best indicates the meta-analysis P value of the best SNP in each individual locus from the two SLE GWASs.  
P_adjusted stands for the P values for each candidate independent SNP, adjusted with the effect from the best reported SNP in each individual locus and potential cohort differences (using cohort as 
a covariate). 
P_unadjusted are the meta-analysis P values of the candidate independent SNPs based on the two SLE GWASs. 
*indicates the LD between each candidate independent SNP and the reported independent SNP, shown as r2 value in CHB+JPT populations. 
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P_adjusted <0.05, and P_unadjusted<0.001 were set as the cutoff for screening candidate independent SNPs. 
 
 
Table 2. Replication results on SNPs in ANXA6 and TNIP1  
SNP 
Hong Kong (1639/3899) An Hui (2507/2599) Thailand (480/968) 
P_combined 
Combined 
OR(95% CI)  
P_het 
conditional 
Pa 
conditional 
P
b
 
Case_F Ctrl_F P_HK Case_F Ctrl_F P_AH Case_F Ctrl_F P_Thai 
rs10036748 0.22 0.26 1.03E-04 0.20 0.25 1.82E-07 0.31 0.33 3.50E-01 1.94E-10 0.81 (0.76-0.86) 0.2703 —— 2.14E-07 
rs4958893 0.27 0.31 2.12E-04 0.30 0.33 8.52E-04 0.33 0.36 1.89E-01 3.12E-07 0.86 (0.81-0.91) 0.8223 2.32E-64 0.009352 
rs11960458 0.48 0.45 4.29E-04 0.48 0.45 1.16E-03 0.34 0.32 1.41E-01 5.66E-07 1.15 (1.09-1.21) 0.9518 8.51E-08 0.002212 
rs6896621 0.33 0.35 4.70E-03 0.32 0.36 2.29E-04 0.40 0.41 6.32E-01 6.72E-06 0.88 (0.83-0.93) 0.4675 6.92E-15 8.15E-05 
rs868531 0.46 0.42 1.62E-03 0.44 0.42 1.86E-02 0.29 0.33 5.56E-02 0.001939 1.09 (1.03-1.15) 0.00826 0.0646   
rs2303028 0.42 0.40 2.34E-02 0.38 0.37 2.08E-01 0.29 0.34 1.83E-02 0.1095 1.05 (0.99-1.11) 0.00748 0.3932   
Arabic numerals in brackets indicate number of cases and controls that used in this study 
Case/Ctrl_F indicates minor allele frequencies of the SNP in cases or controls 
a 
P values for each of the five replicated SNPs adjusting for the effect of rs10036748 from all the samples, while treating cohort as a covariate. 
b
 For the four SNPs, rs10036748, rs4958893, rs11960458 and rs6896621, we show  the P value of the SNP when adjusted by the effect of the other three SNPs.
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Figure 1. Flowchart of the experimental process and SNP selection criteria.  
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Figure 2. Associated SNPs in TNIP1-ANXA6 region and LD patterns among these SNPs in the current study. 
(a) SNPs are plotted by chromosomal position (NCBI genome build 36.3; x axis) and meta-analysis P values 
(-log10P value; y axis). SNP rs4958893, having the strongest signal of ANXA6, is labeled in the plot, and 
other SNPs are colored to reflect their LD with rs4958893 (based on pairwise r2 values from the meta-
analysis data). The reported SNP in TNIP1 (rs10036748) is underlined. Estimated recombination rates (from 
HapMap CHB+JPT samples) are plotted to reflect the local LD structure. The figure was generated using 
SNAP. (b) Shown are r2 values for CHB+JPT individuals in HapMap3 Release 2. Stars point to the reported 
SNP in TNIP1 gene.  
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Figure 3. Allelic differential expression of ANXA6 based on SNP rs11960458 in PBMCs of healthy individuals. 
PBMC cDNA and DNA prepared from 43 healthy individuals heterozygous on rs11960458 were used for 
allelic differential expression analysis of ANXA6 by pyrosequencing. Shown are the ratio of T/C allelic 
detection for both DNA and cDNA. The median T/C ratio for DNA is 1.08 (95% CI: 1.07-1.11) and the 
median T/C ratio for cDNA expression is 1.18 (95% CI: 1.15-1.29), P=0.0017 by paired student’s t test on 
the difference of the ratios.  
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Figure 4. Summary of association result of ANXA6 with SLE and its potential functional link with 
autoimmunity.  
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